Terms: = Head and neck cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Prognosis
233 results:
1. Somatic mutations of esophageal adenocarcinoma: a comparison between Black and White patients.
Lim H; Gingras MC; Zhao J; Byun J; Castro PD; Tsavachidis S; Hu J; Doddapaneni H; Han Y; Muzny DM; Gibbs RA; Amos CI; Thrift AP
Sci Rep; 2024 Apr; 14(1):8988. PubMed ID: 38637560
[TBL] [Abstract] [Full Text] [Related]
2. Esophageal adenocarcinoma heterogeneity in clinicopathology and prognosis: A single center longitudinal study of 146 cases over a 20-year period.
Huang Q; Lew E; Cheng Y; Shinagare S; Deshpande V; Gold JS; Wiener D; Weber HC
Ann Diagn Pathol; 2024 Jun; 70():152285. PubMed ID: 38518703
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological, metastatic and prognostic features of stage IV esophageal adenocarcinoma versus squamous cell carcinoma: a SEER database analysis.
Pan L; Zhang Y; Gao Y; Qiu J
Chin Clin Oncol; 2024 Feb; 13(1):2. PubMed ID: 38372056
[TBL] [Abstract] [Full Text] [Related]
4. Occupational asbestos exposure and risk of esophageal cancer: A systematic review and meta-analysis.
Seyyedsalehi MS; Boffetta P
Int J Cancer; 2024 Jun; 154(11):1920-1929. PubMed ID: 38339891
[TBL] [Abstract] [Full Text] [Related]
5. The Expression Patterns and Implications of
Syllaios A; Gazouli M; Vailas M; Mylonas KS; Sakellariou S; Sougioultzis S; Karavokyros I; Liakakos T; Schizas D
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203269
[TBL] [Abstract] [Full Text] [Related]
6. Esophageal cancer: a twenty-four-year experience at a tertiary care center with an evaluation of the prognostic significance of the neutrophil-lymphocyte ratio.
Mahmoud W; Hassoun L; Kerbage A; Mukherji D; Shamseddine A; Tamraz S; Hakim A; Barada K
BMC Gastroenterol; 2024 Jan; 24(1):27. PubMed ID: 38195445
[TBL] [Abstract] [Full Text] [Related]
7. Total thyroidectomy versus unilateral lobectomy for unilateral multifocal papillary thyroid carcinoma: systematic review and meta‑analysis.
Chen H; Liu Y; Huang D; Zhang X; She L
Updates Surg; 2024 Jan; 76(1):33-41. PubMed ID: 38127193
[TBL] [Abstract] [Full Text] [Related]
8. The association between histological subtypes and lymph node metastasis and prognosis in early esophageal cancer: a population-based study.
Lin JP; Chen XF; Zhou H; Zhuang FN; He H; Chen WJ; Wang F; Liu SY
Eur J Cancer Prev; 2024 Mar; 33(2):152-160. PubMed ID: 37991237
[TBL] [Abstract] [Full Text] [Related]
9. The function and immune role of cuproptosis associated hub gene in Barrett's esophagus and esophageal adenocarcinoma.
Lin K; Hu K; Chen Q; Wu J
Biosci Trends; 2023 Nov; 17(5):381-392. PubMed ID: 37866883
[TBL] [Abstract] [Full Text] [Related]
10. ESOMIR: a curated database of biomarker genes and miRNAs associated with esophageal cancer.
Sindhoo A; Sipy S; Khan A; Selvaraj G; Alshammari A; Casida ME; Wei DQ
Database (Oxford); 2023 Oct; 2023():. PubMed ID: 37815872
[TBL] [Abstract] [Full Text] [Related]
11. The prognostic impact of tumor length on pathological stage IA-IC esophageal adenocarcinoma.
Yan S; Liu X; Xing W; Jiang D; Feng SK; Chang AC; Sun HB
Dis Esophagus; 2024 Jan; 37(1):. PubMed ID: 37455547
[TBL] [Abstract] [Full Text] [Related]
12. Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction.
Gebauer F; Plum PS; Damanakis A; Chon SH; Popp F; Zander T; Quaas A; Fuchs H; Schmidt T; Schröder W; Bruns CJ
Ann Surg Oncol; 2023 Nov; 30(12):7422-7433. PubMed ID: 37210683
[TBL] [Abstract] [Full Text] [Related]
13. cancer Risk in Barrett's Esophagus: A Clinical Review.
Beydoun AS; Stabenau KA; Altman KW; Johnston N
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37046992
[TBL] [Abstract] [Full Text] [Related]
14. Tumor-Derived CCL5 Recruits cancer-Associated Fibroblasts and Promotes Tumor Cell Proliferation in Esophageal Squamous Cell Carcinoma.
Dunbar KJ; Karakasheva TA; Tang Q; Efe G; Lin EW; Harris M; Sahu V; Sachdeva UM; Hu J; Klein-Szanto AJ; Henick B; Diehl JA; Nakagawa H; Rustgi AK
Mol Cancer Res; 2023 Jul; 21(7):741-752. PubMed ID: 37027010
[TBL] [Abstract] [Full Text] [Related]
15. Patients with esophageal adenocarcinoma showed better prognosis than those with adenocarcinoma of the gastroesophageal junction.
Huang Q; Cheng Y; Lew E; Shi J; Wiener D; Weber HC
J Dig Dis; 2023 Feb; 24(2):98-112. PubMed ID: 36970757
[TBL] [Abstract] [Full Text] [Related]
16. T-cell exhaustion: A potential target biomarker of the tumour microenvironment affecting oesophageal adenocarcinoma.
Peng S; Han X; Geng W; Zhao L
J Gene Med; 2023 Jul; 25(7):e3496. PubMed ID: 36879295
[TBL] [Abstract] [Full Text] [Related]
17. Biomarkers for Early Detection, prognosis, and Therapeutics of Esophageal cancers.
Rai V; Abdo J; Agrawal DK
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834728
[TBL] [Abstract] [Full Text] [Related]
18. Long-term analysis of prognostic risk factors impacting surgical outcomes in patients with external auditory canal carcinoma.
Lohnherr V; Wurzrainer N; Sand M; Federspil P; Hess J; Zaoui K; Plath M
Eur Arch Otorhinolaryngol; 2023 Jun; 280(6):2965-2974. PubMed ID: 36806747
[TBL] [Abstract] [Full Text] [Related]
19. Identification of potential biomarkers in Barrett's esophagus derived esophageal adenocarcinoma.
Yi N; Zhao H; He J; Xie X; Liang L; Zuo G; Xiong M; Liang Y; Yi T
Sci Rep; 2023 Feb; 13(1):2345. PubMed ID: 36759514
[TBL] [Abstract] [Full Text] [Related]
20. Pathological complete response in multimodal treatment of esophageal cancer: a retrospective cohort study.
Hipp J; Kuvendjiska J; Hillebrecht HC; Timme-Bronsert S; Fichtner-Feigl S; Hoeppner J; Diener MK
Dis Esophagus; 2023 Jul; 36(7):. PubMed ID: 36572398
[TBL] [Abstract] [Full Text] [Related]
[Next]
